Education
About Us
Working with TipRanks
Follow Us
Brainsway (BRSYF)
:BRSYF
BRSYF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.10 - $8.53
Previous CloseN/A
Volume2.42K
Average Volume (3M)6.00
Market Cap
$298.61M
Enterprise Value$599.47M
Total Cash (Recent Filing)$78.00M
Total Debt (Recent Filing)$6.13M
Price to Earnings (P/E)38.1
Beta-0.58
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding37,803,593
10 Day Avg. Volume0
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.01
Enterprise Value/Revenue13.01
Enterprise Value/Gross Profit17.46
Enterprise Value/Ebitda70.85
Forecast
1Y Price Target
$8.68Price Target Upside58.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Brainsway News
BRSYF FAQ
What was Brainsway ’s price range in the past 12 months?
Brainsway lowest stock price was $2.10 and its highest was $8.53 in the past 12 months.
What is Brainsway ’s market cap?
Brainsway ’s market cap is $298.61M.
When is Brainsway ’s upcoming earnings report date?
Brainsway ’s upcoming earnings report date is Nov 12, 2025 which is in 63 days.
How were Brainsway ’s earnings last quarter?
Brainsway released its earnings results on Aug 13, 2025. The company reported $0.057 earnings per share for the quarter, beating the consensus estimate of N/A by $0.057.
Is Brainsway overvalued?
According to Wall Street analysts Brainsway ’s price is currently Undervalued.
Does Brainsway pay dividends?
Brainsway does not currently pay dividends.
What is Brainsway ’s EPS estimate?
Brainsway ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway have?
Brainsway has 37,803,593 shares outstanding.
What happened to Brainsway ’s price movement after its last earnings report?
Brainsway reported an EPS of $0.057 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Brainsway ?
Currently, no hedge funds are holding shares in BRSYF
Company Description
Brainsway
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BRSYF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights significant revenue growth, strong market presence, and strategic investments, suggesting positive momentum despite increased operating expenses and pending regulatory approvals.View all BRSYF earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.35% Mutual Funds
0.24% Other Institutional Investors
99.06% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---